Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod-Reference-Cited by-同舟云学术

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod

Published:2015-09-10 Issue:9 Volume:16 Page:21832-21845
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Harrer Andrea,Wipfler Peter,Pilz Georg,Oppermann Katrin,Haschke-Becher Elisabeth,Afazel Shahrzad,Kraus Jörg,Trinka Eugen,Sellner Johann

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/16/9/21832/pdf

Reference37 articles.

1. Herpes Zoster: Diagnostic, Therapeutic, and Preventive Approaches

2. The challenging patient with varicella-zoster virus disease

3. VZV T cell-mediated immunity;Weinberg;Curr. Top. Microbiol. Immunol.,2010

4. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system

5. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T Lymphocyte Subsets Profile and Toll-Like Receptors Responses in Patients with Herpes Zoster;Journal of Pain Research;2023-05

2. Acute Varicella-Zoster Virus meningitis in a multiple sclerosis patient treated with fingolimod;Revue Neurologique;2022-04

3. Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications;Journal of Neurology, Neurosurgery & Psychiatry;2020-11-23

4. Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2020-02

5. Risks and risk management in modern multiple sclerosis immunotherapeutic treatment;Therapeutic Advances in Neurological Disorders;2019-01